Afsheen Raza
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Oncology 16
- Cancer Immunotherapy and Biomarkers 8
- Cancer Cells and Metastasis 4
- Co-authors
- Shahab Uddin (23 shared papers)Mohammad Haris (2 shared papers)Said Dermime (19 shared papers)Selma Maacha (1 shared paper)Jean‐Charles Grivel (1 shared paper)Lizandra Jimenez (1 shared paper)Ajaz A. Bhat (1 shared paper)Maysaloun Merhi (12 shared papers)
- Journals
- Malaria Journal (4 papers)Cancers (3 papers)Frontiers in Immunology (3 papers)Frontiers in Oncology (3 papers)Biomedicine & Pharmacotherapy (2 papers)
- Partner nations
- QatarPakistanUnited Arab Emirates
In The Last Decade
Afsheen Raza
53 papers receiving 1.5k citations
Afsheen Raza's Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 355
- Infectious Diseases 185
- Immunology 212
- Molecular Biology 697
- Oncology 242
Countries citing papers authored by Afsheen Raza
This map shows the geographic impact of Afsheen Raza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afsheen Raza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afsheen Raza more than expected).
Fields of papers citing papers by Afsheen Raza
This network shows the impact of papers produced by Afsheen Raza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afsheen Raza. The network helps show where Afsheen Raza may publish in the future.
Co-authors
The 25 scholars most cited alongside Afsheen Raza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance Hit paper breakdown → | 2019 | 423 |
| 2 | Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines Hit paper breakdown → | 2022 | 269 |
| 3 | 2022 | 98 | |
| 4 | 2020 | 73 | |
| 5 | 2020 | 63 | |
| 6 | 2019 | 46 | |
| 7 | 2018 | 39 | |
| 8 | 2019 | 39 | |
| 9 | 2021 | 36 | |
| 10 | 2013 | 33 | |
| 11 | 2020 | 30 | |
| 12 | 2013 | 28 | |
| 13 | 2013 | 27 | |
| 14 | 2024 | 26 | |
| 15 | 2018 | 23 | |
| 16 | 2021 | 23 | |
| 17 | 2022 | 17 | |
| 18 | 2018 | 17 | |
| 19 | 2023 | 16 | |
| 20 | 2013 | 13 |
About Afsheen Raza
Afsheen Raza is a scholar working on Molecular Biology, Oncology, Public Health, Environmental and Occupational Health, Immunology and Cancer Research, having authored 57 papers that have together received 1.5k indexed citations. Recurring topics across this work include Malaria Research and Control (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (5 papers), Cancer Cells and Metastasis (4 papers), Mosquito-borne diseases and control (4 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (355 citations), Infectious Diseases (185 citations), Immunology (212 citations), Molecular Biology (697 citations) and Oncology (242 citations). Afsheen Raza has collaborated with scholars based in Qatar, Pakistan and United Arab Emirates. Frequent co-authors include Shahab Uddin, Mohammad Haris, Said Dermime, Selma Maacha, Jean‐Charles Grivel, Lizandra Jimenez, Ajaz A. Bhat, Maysaloun Merhi, Varghese Inchakalody and Queenie Fernandes. Their work appears in journals such as Malaria Journal, Cancers, Frontiers in Immunology, Frontiers in Oncology and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.